Clinical Trial Update: Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of transdermal buprenorphine for radiation-induced mucositis pain in patients with head and neck squamous cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Buprenorphine transdermal patch (buprenorphine)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2025-04-20